Harpoon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch HARP and buy or sell other stocks, options, and ETFs commission-free!About HARP
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.
CEOJulia Marie Eastland, MBA
CEOJulia Marie Eastland, MBA
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees—
Employees—
HARP Key Statistics
Market cap94.54M
Market cap94.54M
Price-Earnings ratio-2.64
Price-Earnings ratio-2.64
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$23.21
52 Week high$23.21
52 Week low$3.11
52 Week low$3.11